Toll Free: 1-888-928-9744
Published: Feb, 2015 | Pages:
52 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Visceral Pain - Pipeline Review, H1 2015 Summary Global Markets Direct's, 'Visceral Pain - Pipeline Review, H1 2015', provides an overview of the Visceral Pain's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Visceral Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Visceral Pain and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Visceral Pain - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Visceral Pain and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Visceral Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Visceral Pain pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reason to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Visceral Pain - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Visceral Pain pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 5 Introduction 6 Global Markets Direct Report Coverage 6 Visceral Pain Overview 7 Therapeutics Development 8 Pipeline Products for Visceral Pain - Overview 8 Pipeline Products for Visceral Pain - Comparative Analysis 9 Visceral Pain - Therapeutics under Development by Companies 10 Visceral Pain - Therapeutics under Investigation by Universities/Institutes 11 Visceral Pain - Pipeline Products Glance 12 Clinical Stage Products 12 Early Stage Products 13 Visceral Pain - Products under Development by Companies 14 Visceral Pain - Products under Investigation by Universities/Institutes 15 Visceral Pain - Companies Involved in Therapeutics Development 16 Amorepacific Corporation 16 Astellas Pharma Inc. 17 GIcare Pharma Inc 18 Grunenthal GmbH 19 Hydra Biosciences, Inc. 20 Nektar Therapeutics 21 Neurim Pharmaceuticals Ltd 22 Trevena, Inc. 23 Visceral Pain - Therapeutics Assessment 24 Assessment by Monotherapy Products 24 Assessment by Target 25 Assessment by Mechanism of Action 27 Assessment by Route of Administration 29 Assessment by Molecule Type 31 Drug Profiles 32 ASP-7663 - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 GIC-1001 - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 GIC-1002 - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 HC-030031 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 NeuP-12 - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 NKTR-195 - Drug Profile 38 Product Description 38 Mechanism of Action 38 R&D Progress 38 PAC-14028 - Drug Profile 39 Product Description 39 Mechanism of Action 39 R&D Progress 39 piromelatine - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 RO-656570 - Drug Profile 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 Small Molecule to Block Nav1.9 Channel for Pain - Drug Profile 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 Small Molecules to Agonize Kappa Opioid Receptor for CNS Disorder - Drug Profile 45 Product Description 45 Mechanism of Action 45 R&D Progress 45 TRV-250 - Drug Profile 46 Product Description 46 Mechanism of Action 46 R&D Progress 46 URB-937 - Drug Profile 47 Product Description 47 Mechanism of Action 47 R&D Progress 47 Visceral Pain - Recent Pipeline Updates 48 Visceral Pain - Dormant Projects 49 Visceral Pain - Discontinued Products 50 Appendix 51 Methodology 51 Coverage 51 Secondary Research 51 Primary Research 51 Expert Panel Validation 51 Contact Us 51 Disclaimer 52
List of Tables Number of Products under Development for Visceral Pain, H1 2015 8 Number of Products under Development for Visceral Pain - Comparative Analysis, H1 2015 9 Number of Products under Development by Companies, H1 2015 10 Number of Products under Investigation by Universities/Institutes, H1 2015 11 Comparative Analysis by Clinical Stage Development, H1 2015 12 Comparative Analysis by Early Stage Development, H1 2015 13 Products under Development by Companies, H1 2015 14 Products under Investigation by Universities/Institutes, H1 2015 15 Visceral Pain - Pipeline by Amorepacific Corporation, H1 2015 16 Visceral Pain - Pipeline by Astellas Pharma Inc., H1 2015 17 Visceral Pain - Pipeline by GIcare Pharma Inc, H1 2015 18 Visceral Pain - Pipeline by Grunenthal GmbH, H1 2015 19 Visceral Pain - Pipeline by Hydra Biosciences, Inc., H1 2015 20 Visceral Pain - Pipeline by Nektar Therapeutics, H1 2015 21 Visceral Pain - Pipeline by Neurim Pharmaceuticals Ltd, H1 2015 22 Visceral Pain - Pipeline by Trevena, Inc., H1 2015 23 Assessment by Monotherapy Products, H1 2015 24 Number of Products by Stage and Target, H1 2015 26 Number of Products by Stage and Mechanism of Action, H1 2015 28 Number of Products by Stage and Route of Administration, H1 2015 30 Number of Products by Stage and Molecule Type, H1 2015 31 Visceral Pain Therapeutics - Recent Pipeline Updates, H1 2015 48 Visceral Pain - Dormant Projects, H1 2015 49 Visceral Pain - Discontinued Products, H1 2015 50
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.